Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-27T03:42:16.678Z Has data issue: false hasContentIssue false
  • English
  • Français

X-ray powder diffraction data for piperaquine, C29H32Cl2N6

Published online by Cambridge University Press:  13 August 2015

Qing Wang ,
Yan Mei Huang ,
Xing Ling Ma ,
Shan Shan Li  and
Hui Li
Qing Wang
Affiliation:
College of Chemical Engineering, Sichuan University, Chengdu 610065, China
Yan Mei Huang
Affiliation:
College of Chemical Engineering, Sichuan University, Chengdu 610065, China
Xing Ling Ma
Affiliation:
College of Chemical Engineering, Sichuan University, Chengdu 610065, China
Shan Shan Li
Affiliation:
College of Chemical Engineering, Sichuan University, Chengdu 610065, China
Hui Li*
Affiliation:
College of Chemical Engineering, Sichuan University, Chengdu 610065, China
*
a)Author to whom correspondence should be addressed. Electronic mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

X-ray powder diffraction data for piperaquine, C29H32Cl2N6, are reported [a = 15.8865(1) Å, b = 12.5975(3) Å, c = 13.2647(3) Å, β = 91.2890(1)°, unit-cell volume V = 2654.02 Å3, Z = 4, and space group P21/n]. All measured lines were indexed and are consistent with the P21/n space group. No detectable impurities were observed.

Keywords

X-ray powder diffractionpiperaquine
Type
New Diffraction Data
Information
Powder Diffraction , Volume 30 , Issue 3 , September 2015 , pp. 289 - 292
Copyright
Copyright © International Centre for Diffraction Data 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Divya, M., Vasanth, P., Ramesh, T., and Ramesh, M. (2014). “Stability indicating RP-HPLC method development for simultaneous determination of arterolane maleate and piperaquine phosphate in bulk and tablet dosage form,” Der Pharm. Lett. 6, 8–15.Google Scholar
Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., and Puschmann, H. (2009). “OLEX2: a complete structure solution, refinement and analysis program,” J. Appl. Crystallogr. 42, 339–341.CrossRefGoogle Scholar
Laskhmi, P. and Mohan Gandhi, B. (2014). “Method development and validation for simultaneous estimation of arterolane maleate and piperaquine phosphate by RP-HPLC,” Int. J. Pharm. Pharm. Sci. 6, 441–444.Google Scholar
Li, S. S., Wu, X. Q., Pan, Q. Q., Cheng, Q., and Li, H. (2014). “Comparison of the accuracy of powder and single crystal X-ray diffraction techniques in determining organic crystal structure,” Chin. Sci. Bull. 59, 497–501.Google Scholar
Reddy, G. S. and Reddy, S. P. (2014). “Development and validation of a stability indicating liquid chromatographic method for simultaneous estimation of arterolane maleate and piperaquine phosphate in combined dosage form,” Orient. J. Chem. 29, 1371–1380.Google Scholar
Sheldrick, G. M. (2008). “Foundations of crystallography,” Acta Crystallogr. A 64, 112–122.CrossRefGoogle Scholar
Wang, Q., Zhang, L. L., Wu, X. Q., Pan, Q. Q., Su, Y. H., and Li, H. (2013). “X-ray powder diffraction data for inclusion complex of β-cyclodextrin with fraxinellone,” Powder Diffr. 28, 234–236.CrossRefGoogle Scholar
Supplementary material: File

Wang supplementary material

Wang supplementary material 1

Download Wang supplementary material(File)
File 476.9 KB
Supplementary material: File

Wang supplementary material

Wang supplementary material 2

Download Wang supplementary material(File)
File 113.9 KB